BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 26692555)

  • 1. Symptom burden, Metabolic profile, Ultrasound findings, Rhythm, neurohormonal activation, haemodynamics and health-related quality of life in patients with atrial Fibrillation (SMURF): a protocol for an observational study with a randomised interventional component.
    Charitakis E; Walfridsson U; Nyström F; Nylander E; Strömberg A; Alehagen U; Walfridsson H
    BMJ Open; 2015 Dec; 5(12):e008723. PubMed ID: 26692555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Predicting Arrhythmia-Related Symptoms and Health-Related Quality of Life in Patients Referred for Radiofrequency Ablation of Atrial Fibrillation: An Observational Study (the SMURF Study).
    Charitakis E; Barmano N; Walfridsson U; Walfridsson H
    JACC Clin Electrophysiol; 2017 May; 3(5):494-502. PubMed ID: 29759606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Term Influence of Radiofrequency Ablation on NT-proBNP, MR-proANP, Copeptin, and MR-proADM in Patients With Atrial Fibrillation: Data From the Observational SMURF Study.
    Charitakis E; Walfridsson H; Alehagen U
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of improvement in arrhythmia-specific symptoms and health-related quality of life after catheter ablation of atrial fibrillation.
    Barmano N; Charitakis E; Karlsson JE; Nystrom FH; Walfridsson H; Walfridsson U
    Clin Cardiol; 2019 Feb; 42(2):247-255. PubMed ID: 30548275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial).
    Osmancik P; Havránek Š; Bulková V; Chovančík J; Roubíček T; Heřman D; Čarná Z; Tuka V; Matoulek M; Fiala M; Jiravský O; Stregl-Hruskova S; Latiňák A; Kotryová J; Jarkovský J
    BMJ Open; 2022 Jun; 12(6):e056522. PubMed ID: 35705334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of catheter ablation as first-line therapy for paroxysmal atrial fibrillation: 5-year outcome in a randomised clinical trial.
    Nielsen JC; Johannessen A; Raatikainen P; Hindricks G; Walfridsson H; Pehrson SM; Englund A; Hartikainen J; Mortensen LS; Hansen PS;
    Heart; 2017 Mar; 103(5):368-376. PubMed ID: 27566295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF).
    Ha AC; Breithardt G; Camm AJ; Crijns HJ; Fitzmaurice GM; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Dorian P
    Circ Cardiovasc Qual Outcomes; 2014 Nov; 7(6):896-904. PubMed ID: 25387780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical ablation of atrial fibrillation: a protocol for a systematic review and meta-analysis of randomised controlled trials.
    McClure GR; Belley-Cote EP; Singal RK; Jaffer IH; Dvirnik N; An KR; Fortin G; Spence J; Whitlock RP
    BMJ Open; 2016 Nov; 6(11):e013273. PubMed ID: 27807090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological versus invasive treatment in patients with atrial fibrillation].
    Pytkowski M; Jankowska A; Kraska A; Sterliński M; Kowalik I; Krzyzanowski W; Szwed H
    Pol Arch Med Wewn; 2004 Jun; 111(6):703-7. PubMed ID: 15508793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal Activation After Atrial Fibrillation Initiation in Patients Eligible for Catheter Ablation: A Randomized Controlled Study.
    Charitakis E; Walfridsson H; Nylander E; Alehagen U
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27956398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat Catheter Ablation of Long-standing Persistent Atrial Fibrillation in Patients with a Total Atrial Fibrillation Duration of More Than 2 Years: Effects of the CHA2DS2-VASc Score and Estimated Glomerular Filtration Rate on the Outcomes.
    Wang Q; Jiang SL; Liu X; Yang YQ
    Intern Med; 2016; 55(18):2537-47. PubMed ID: 27629945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.
    Wokhlu A; Monahan KH; Hodge DO; Asirvatham SJ; Friedman PA; Munger TM; Bradley DJ; Bluhm CM; Haroldson JM; Packer DL
    J Am Coll Cardiol; 2010 May; 55(21):2308-16. PubMed ID: 20488300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting favourable outcomes in the setting of radiofrequency catheter ablation of long-standing persistent atrial fibrillation: a pilot study assessing the value of left atrial appendage peak flow velocity.
    Combes S; Jacob S; Combes N; Karam N; Chaumeil A; Guy-Moyat B; Treguer F; Deplagne A; Boveda S; Marijon E; Albenque JP
    Arch Cardiovasc Dis; 2013 Jan; 106(1):36-43. PubMed ID: 23374970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial injury biomarkers after radiofrequency catheter and cryoballoon ablation for atrial fibrillation and their impact on recurrence.
    Kızılırmak F; Gokdeniz T; Gunes HM; Demir GG; Cakal B; Guler GB; Guler E; Olgun FE; Kilicaslan F
    Kardiol Pol; 2017; 75(2):126-134. PubMed ID: 27221959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure.
    Beukema WP; Sie HT; Misier AR; Delnoy PP; Wellens HJ; Elvan A
    Eur J Cardiothorac Surg; 2008 Oct; 34(4):771-5. PubMed ID: 18768326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation.
    den Uijl DW; Delgado V; Bertini M; Tops LF; Trines SA; van de Veire NR; Zeppenfeld K; Schalij MJ; Bax JJ
    Heart; 2011 Nov; 97(22):1847-51. PubMed ID: 21357370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Complex Weight-Reducing Interventions on Rhythm Control in Obese Individuals with Atrial Fibrillation Following Catheter Ablation: A Study Protocol.
    Štolbová K; Novodvorský P; Jakubíková I; Dvořáková I; Mráz M; Wichterle D; Kautzner J; Haluzík M
    Adv Ther; 2021 Apr; 38(4):2007-2016. PubMed ID: 33710588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis.
    Njoku A; Kannabhiran M; Arora R; Reddy P; Gopinathannair R; Lakkireddy D; Dominic P
    Europace; 2018 Jan; 20(1):33-42. PubMed ID: 28444307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial.
    Mantovan R; Macle L; De Martino G; Chen J; Morillo CA; Novak P; Calzolari V; Khaykin Y; Guerra PG; Nair G; Torrecilla EG; Verma A
    Can J Cardiol; 2013 Oct; 29(10):1211-7. PubMed ID: 23988341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.